The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

The investment, which is expected to be complete by 2030, will boost U.S. production of Roche’s continuous glucose monitoring ...

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030.

Roche plans to invest as much as $550 million in its Indianapolis diagnostics campus during the next five years, with plans to build it into a U.S. | The announcement follows a five-year, $50 billion ...

A digital health application (DiGA) has been shown to relieve the distress that patients can experience when managing diabetes ... alongside products like its Accu-Chek blood glucose testing ...

INDIANAPOLIS — Roche has announced plans to invest up to $550 million in its Diagnostics facility in Indianapolis by 2030.

It houses research and development, laboratories, manufacturing and other functions, and produces Roche’s Accu-Chek diabetes test strips. The facility is one of two global distribution hubs for ...

The facility produces about 5.2 billion Accu-Chek diabetes test strips annually and serves as one of the company’s two global distribution hubs focused on serving the U.S. market and supporting ...